DAFNA Capital Management’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-168,763
Closed -$21.6M 77
2025
Q2
$21.6M Buy
168,763
+16,500
+11% +$1.71M 5.97% 4
2025
Q1
$13.5M Buy
152,263
+2,500
+2% +$244K 3.82% 7
2024
Q4
$13.1M Buy
149,763
+28,000
+23% +$2.56M 3.32% 10
2024
Q3
$11.3M Buy
121,763
+17,000
+16% +$1.69M 2.66% 11
2024
Q2
$11.3M Sell
104,763
-2,000
-2% -$200K 2.7% 10
2024
Q1
$10.1M Sell
106,763
-4,100
-4% -$352K 2.31% 13
2023
Q4
$10.2M Sell
110,863
-138,658
-56% -$8.98M 2.45% 12
2023
Q3
$12.5M Sell
249,521
-2,000
-0.8% -$107K 3.9% 8
2023
Q2
$15.9M Sell
251,521
-9,714
-4% -$528K 4.35% 4
2023
Q1
$11.8M Hold
261,235
3.52% 8
2022
Q4
$11.4M Hold
261,235
3.22% 8
2022
Q3
$17.2M Sell
261,235
-45
-0% -$2.89K 4.63% 3
2022
Q2
$13.2M Buy
261,280
+15,000
+6% +$879K 3.6% 7
2022
Q1
$15.7M Buy
246,280
+39,369
+19% +$2.83M 4.1% 4
2021
Q4
$22.2M Hold
206,911
5.57% 2
2021
Q3
$21.3M Sell
206,911
-1,000
-0.5% -$93.1K 5.64% 2
2021
Q2
$18.3M Hold
207,911
3.82% 4
2021
Q1
$20.2M Buy
207,911
+1,000
+0.5% +$99.8K 4.8% 3
2020
Q4
$23.2M Sell
206,911
-26,178
-11% -$2.76M 6.9% 3
2020
Q3
$21.6M Buy
233,089
+5,000
+2% +$385K 7.02% 3
2020
Q2
$17.8M Hold
228,089
5.13% 2
2020
Q1
$13.3M Buy
228,089
+104,871
+85% +$6.75M 5.57% 2
2019
Q4
$9.87M Hold
123,218
3.39% 5
2019
Q3
$9.05M Hold
123,218
3.4% 4
2019
Q2
$11.6M Buy
123,218
+3,500
+3% +$289K 4.37% 3
2019
Q1
$9.58M Buy
119,718
+27,027
+29% +$2M 4.13% 3
2018
Q4
$5M Hold
92,691
2.48% 10
2018
Q3
$7.24M Hold
92,691
2.97% 7
2018
Q2
$5.88M Buy
92,691
+4,000
+5% +$318K 2.76% 9
2018
Q1
$8.13M Sell
88,691
-12,000
-12% -$1.03M 3.96% 4
2017
Q4
$7.59M Buy
100,691
+24,691
+32% +$1.74M 4.09% 2
2017
Q3
$5.29M Sell
76,000
-6,000
-7% -$321K 3.29% 8
2017
Q2
$4.16M Sell
82,000
-500
-0.6% -$21.2K 2.96% 6
2017
Q1
$3.3M Buy
82,500
+10,000
+14% +$358K 2.79% 7
2016
Q4
$2.03M Buy
+72,500
New +$2.19M 1.79% 22
2016
Q3
Sell
-10,100
Closed -$205K 83
2016
Q2
$205K Buy
+10,100
New +$184K 0.16% 76

Other funds holding BPMC